199 related articles for article (PubMed ID: 8197195)
1. The human Ha-ras oncogene induces genomic instability in murine fibroblasts within one cell cycle.
Denko NC; Giaccia AJ; Stringer JR; Stambrook PJ
Proc Natl Acad Sci U S A; 1994 May; 91(11):5124-8. PubMed ID: 8197195
[TBL] [Abstract][Full Text] [Related]
2. Mitotic and post mitotic consequences of genomic instability induced by oncogenic Ha-ras.
Denko N; Stringer J; Wani M; Stambrook P
Somat Cell Mol Genet; 1995 Jul; 21(4):241-53. PubMed ID: 8525430
[TBL] [Abstract][Full Text] [Related]
3. Increased methotrexate resistance and dhfr gene amplification as a consequence of induced Ha-ras expression in NIH 3T3 cells.
Wani MA; Xu X; Stambrook PJ
Cancer Res; 1994 May; 54(9):2504-8. PubMed ID: 8162600
[TBL] [Abstract][Full Text] [Related]
4. A ribozyme specifically suppresses transformation and tumorigenicity of Ha-ras-oncogene-transformed NIH/3T3 cell lines.
Chang MY; Won SJ; Liu HS
J Cancer Res Clin Oncol; 1997; 123(2):91-9. PubMed ID: 9030247
[TBL] [Abstract][Full Text] [Related]
5. Chromosomal rearrangements involving telomeric DNA sequences in Balb/3T3 cells transfected with the Ha-ras oncogene.
Peitl P; Mello SS; Camparoto ML; Passos GA; Hande MP; Cardoso RS; Sakamoto-Hojo ET
Mutagenesis; 2002 Jan; 17(1):67-72. PubMed ID: 11752236
[TBL] [Abstract][Full Text] [Related]
6. Transfected c-Ha-ras oncogene enhances karyotypic instability and integrates predominantly in aberrant chromosomes.
de Vries JE; Kornips FH; Marx P; Bosman FT; Geraedts JP; ten Kate J
Cancer Genet Cytogenet; 1993 May; 67(1):35-43. PubMed ID: 8504397
[TBL] [Abstract][Full Text] [Related]
7. Selective activation of oncogenic Ha-ras-induced apoptosis in NIH/3T3 cells.
Liu HS; Chen CY; Lee CH; Chou YI
Br J Cancer; 1998 Jun; 77(11):1777-86. PubMed ID: 9667646
[TBL] [Abstract][Full Text] [Related]
8. Mutational activation of the cellular Harvey ras oncogene in rat esophageal papillomas induced by methylbenzylnitrosamine.
Wang Y; You M; Reynolds SH; Stoner GD; Anderson MW
Cancer Res; 1990 Mar; 50(5):1591-5. PubMed ID: 2406014
[TBL] [Abstract][Full Text] [Related]
9. Selective activation of Ha-ras(val12) oncogene increases susceptibilityof NIH/3T3 cells to TNF-alpha.
Chang MY; Won SJ; Yang BC; Jan MS; Liu HS
Exp Cell Res; 1999 May; 248(2):589-98. PubMed ID: 10222151
[TBL] [Abstract][Full Text] [Related]
10. Dominant-negative Rac1 suppresses Ras-induced apoptosis possibly through activation of NFkappaB in Ha-ras oncogene-transformed NIH/3T3 cells.
Chou CK; Liang KH; Tzeng CC; Huang GC; Chuang JI; Chang TY; Liu HS
Life Sci; 2006 Mar; 78(16):1823-9. PubMed ID: 16274703
[TBL] [Abstract][Full Text] [Related]
11. Ha-rasVal12 oncogene increases susceptibility of NIH/3T3 cells to lovastatin.
Chang MY; Jan MS; Won SJ; Liu HS
Biochem Biophys Res Commun; 1998 Jul; 248(1):62-8. PubMed ID: 9675086
[TBL] [Abstract][Full Text] [Related]
12. Control of Ha-ras-mediated mammalian cell transformation by Escherichia coli regulatory elements.
Liu HS; Scrable H; Villaret DB; Lieberman MA; Stambrook PJ
Cancer Res; 1992 Feb; 52(4):983-9. PubMed ID: 1737361
[TBL] [Abstract][Full Text] [Related]
13. Expression of the c-Ha-ras oncogene in mouse NIH 3T3 cells induces resistance to cisplatin.
Isonishi S; Hom DK; Thiebaut FB; Mann SC; Andrews PA; Basu A; Lazo JS; Eastman A; Howell SB
Cancer Res; 1991 Nov; 51(21):5903-9. PubMed ID: 1657373
[TBL] [Abstract][Full Text] [Related]
14. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
Goodrow T; Reynolds S; Maronpot R; Anderson M
Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
[TBL] [Abstract][Full Text] [Related]
15. The inducible lactose operator-repressor system is functional in the whole animal.
Wu JD; Hsueh HC; Huang WT; Liu HS; Leung HW; Ho YR; Lin MT; Lai MD
DNA Cell Biol; 1997 Jan; 16(1):17-22. PubMed ID: 9022041
[TBL] [Abstract][Full Text] [Related]
16. c-Ha-rasVal 12 oncogene-transformed NIH-3T3 fibroblasts display more decondensed nucleosomal organization than normal fibroblasts.
Laitinen J; Sistonen L; Alitalo K; Hölttä E
J Cell Biol; 1990 Jul; 111(1):9-17. PubMed ID: 2195041
[TBL] [Abstract][Full Text] [Related]
17. Transformation of normal homologous cells by a spontaneously activated Ha-ras oncogene.
Schwartz SA; Shuler CF; Freebeck P
Cancer Res; 1988 Jun; 48(12):3470-7. PubMed ID: 3285996
[TBL] [Abstract][Full Text] [Related]
18. Activating mutations of the c-Ha-ras protooncogene in chemically induced hepatomas of the male B6C3 F1 mouse.
Wiseman RW; Stowers SJ; Miller EC; Anderson MW; Miller JA
Proc Natl Acad Sci U S A; 1986 Aug; 83(16):5825-9. PubMed ID: 3016723
[TBL] [Abstract][Full Text] [Related]
19. Human retinoblastoma gene product prevents c-Ha-ras oncogene mediated cellular transformation of mouse fibroblasts.
Kivinen L; Pitkänen K; Laiho M
Oncogene; 1993 Oct; 8(10):2703-11. PubMed ID: 8378082
[TBL] [Abstract][Full Text] [Related]
20. Cytoskeletal reorganization in NIH 3T3 fibroblasts expressing the ras oncogene.
Dartsch PC; Ritter M; Häussinger D; Lang F
Eur J Cell Biol; 1994 Apr; 63(2):316-25. PubMed ID: 8082656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
